Keveyis |
dichlorphenamide
|
01/01/2019 |
|
Electrolyte Disorders |
Kevzara |
sarilumab
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Rheumatoid Arthritis |
Keytruda |
Pembrolizumab
|
01/01/2017 |
|
Oncology |
Khapzory |
Levoleucovorin
|
01/01/2017 |
|
Oncology |
Kineret |
anakinra
|
01/01/2018 |
- Requires Excluded Exception Approval
|
Rheumatoid Arthritis |
Kisqali |
ribociclib
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Oncology |
Kisqali-Femara |
ribociclib-letrozole
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Oncology |
Kitabis Pak |
tobramycin inhalation
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Cystic Fibrosis |
Klaron |
sodium sulfacetamide lotion
|
09/01/2017 |
- Requires Prior Approval
- Requires Step Therapy
|
Topical Acne Products |
Klofensaid II |
diclofenac sodium topical solution 1.5%
|
01/01/2019 |
- Requires Prior Approval
- Subject to Quantity Limits
|
COX-2/NSAIDs |
Koate-DVI |
Antihemophilic factor VIII
|
01/01/2017 |
|
Hemophilia |
Kogenate FS |
Antihemophilic factor VIII
|
10/01/2017 |
|
Hemophilia |
Korlym |
mifepristone
|
01/01/2017 |
|
Cushing's Syndrome |
Kovaltry |
Antihemophilic factor VIII
|
10/01/2017 |
|
Hemophilia |
Krystexxa |
Pegloticase
|
01/01/2017 |
|
Gout |
Kuvan |
sapropterin dihydrochloride
|
01/01/2017 |
|
Phenylketonuria (PKU) |
Kynamro |
mipomersen sodium injection
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Lipid Disorders |
Kynmobi |
apomorphine hydrochloride
|
08/01/2020 |
|
Movement Disorders |
Kyprolis |
Carfilzomib
|
01/01/2017 |
|
Oncology |
Lartruvo |
olaratumab
|
01/01/2018 |
|
Oncology |
Latuda |
lurasidone
|
10/01/2019 |
|
Atypical Antipsychotics |
Lazanda |
fentanyl nasal spray
|
01/01/2017 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Oral/Intranasal Fentanyl Products |
Lemtrada |
alemtuzumab
|
01/01/2018 |
|
Multiple Sclerosis |
Lenvima |
Lenvatinib
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Oncology |
Letairis |
ambrisentan tablets
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Pulmonary Arterial Hypertension |
Leukine |
sargramostim
|
01/01/2017 |
|
Neutropenia |
Levorphanol |
levorphanol tartrate
|
03/01/2018 |
- Requires Prior Approval
- Requires Step Therapy
- Subject to Quantity Limits
|
Opioid Analgesics |
Lexette (Brand Only) |
halobetasol foam
|
01/01/2019 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Corticosteroid |
Lexiva |
fosamprenavir
|
01/01/2018 |
- Subject to Quantity Limits
|
HIV |
Libtayo |
cemiplimab-rwlc
|
01/01/2019 |
- Requires Excluded Exception Approval
|
Oncology |
Lidocaine 5% Ointment |
Lidocaine
|
01/01/2017 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Topical Anesthetics - Lidocaine Containing |
Lidocaine Gel - 2% and 4% |
Lidocaine
|
01/01/2017 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Topical Anesthetics - Lidocaine Containing |
Lidocaine HCL 4% Solution |
Lidocaine
|
01/01/2017 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Topical Anesthetics - Lidocaine Containing |
Lidoderm |
lidocaine patch 5%
|
10/01/2017 |
|
Topical Anesthetics - Lidocaine Containing |
Locoid (Brand Only) |
hydrocortisone butyrate
|
01/01/2019 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Corticosteroid |
Lokara (Brand Only) |
desonide
|
01/01/2019 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Corticosteroid |
Lonsurf |
Trifluridine; Tipiracil
|
01/01/2017 |
|
Oncology |
Lorbrena |
lorlatinib
|
01/01/2019 |
- Requires Excluded Exception Approval
|
Oncology |
Lovaza |
omega-3-acid ethyl esters capsules
|
01/01/2017 |
|
Omega-3 Fatty Acids |
Lucentis |
Ranibizumab
|
01/01/2017 |
|
Retinal Disorders |
Lumizyme |
Alglucosidase alfa
|
01/01/2017 |
|
Lysosomal Storage Disorders |
Lumoxiti |
moxetumomab pasudotox-tdfk
|
01/01/2019 |
- Requires Excluded Exception Approval
|
Oncology |
Lunesta |
eszopiclone
|
01/01/2017 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Sedative-Hypnotics |
Lupaneta |
Leuprolide; Norethindrone
|
01/01/2017 |
|
Hormonal Therapies |
Lupron |
leuprolide
|
01/01/2017 |
|
Fertility Products - Specialty |
Lupron Depot PED |
leuprolide acetate for depot suspension
|
01/01/2018 |
|
Hormonal Therapies |
Lutathera |
lutetium Lu 117 dotatate
|
01/01/2017 |
|
Oncology |
Luxiq (Brand Only) |
betamethasone valerate
|
01/01/2019 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Corticosteroid |
Lynparza |
Olaparib
|
01/01/2018 |
- Requires Prior Approval
- Subject to Quantity Limits
|
Oncology |
Makena |
hydroxyprogesterone caproate injection
|
01/01/2018 |
|
Progestin |